Here’s what you should know:
1. The online sales giant recently registered the domain AmazonRX.com, but analysts are debating the company’s intent.
2. Jefferies analysts Brian Tanquilut believes Amazon could enter the medical device business, while Wells Fargo speculates the company will sell pharmaceuticals.
3. Mr. Tanquilut examined a license granted in Nevada. On it, Amazon didn’t disclose it would handle controlled substances. Although there are prescriptions that are uncontrolled, Mr. Tanquilut believes it represents a move towards medical devices.
4. Amazon posted a business-to-business medical device web page around the same time the company was awarded wholesale distribution licenses in several U.S. states.
5. Amazon told CNBC the company doesn’t, “comment on rumors or speculation.”
More articles on supply chain:
Dr. M. Jonathan Worsey earns national supply chain award — 4 insights
FDA creates medical device development tool program to speed up evaluation, approval process — 4 insights
Hurricanes Irma, Maria could create medical device shortages — 6 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.